142 related articles for article (PubMed ID: 36593900)
1. Correlation Analysis of Gene and Radiomic Features in Colorectal Cancer Liver Metastases.
Wang X; Li N; Guo H; Yin X; Zheng Y
Comput Math Methods Med; 2022; 2022():8559011. PubMed ID: 36593900
[TBL] [Abstract][Full Text] [Related]
2. A radiomics model fusing clinical features to predict microsatellite status preoperatively in colorectal cancer liver metastasis.
Wang X; Liu Z; Yin X; Yang C; Zhang J
BMC Gastroenterol; 2023 Sep; 23(1):308. PubMed ID: 37700238
[TBL] [Abstract][Full Text] [Related]
3. Relationship between KRAS mutations and dual time point
Mao W; Zhou J; Zhang H; Qiu L; Tan H; Hu Y; Shi H
Abdom Radiol (NY); 2019 Jun; 44(6):2059-2066. PubMed ID: 30143816
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
5. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
6. Treatment response prediction using MRI-based pre-, post-, and delta-radiomic features and machine learning algorithms in colorectal cancer.
Shayesteh S; Nazari M; Salahshour A; Sandoughdaran S; Hajianfar G; Khateri M; Yaghobi Joybari A; Jozian F; Fatehi Feyzabad SH; Arabi H; Shiri I; Zaidi H
Med Phys; 2021 Jul; 48(7):3691-3701. PubMed ID: 33894058
[TBL] [Abstract][Full Text] [Related]
7. Association Between the Size and 3D CT-Based Radiomic Features of Breast Cancer Hepatic Metastasis.
Velichko YS; Mozafarykhamseh A; Trabzonlu TA; Zhang Z; Rademaker AW; Yaghmai V
Acad Radiol; 2021 Apr; 28(4):e93-e100. PubMed ID: 32303447
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive CT radiomic model for preoperative prediction of lymph node metastasis in early cervical carcinoma.
Chen J; He B; Dong D; Liu P; Duan H; Li W; Li P; Wang L; Fan H; Wang S; Zhang L; Tian J; Huang Z; Chen C
Br J Radiol; 2020 Apr; 93(1108):20190558. PubMed ID: 31957473
[TBL] [Abstract][Full Text] [Related]
10. Radiogenomics-based cancer prognosis in colorectal cancer.
Badic B; Hatt M; Durand S; Jossic-Corcos CL; Simon B; Visvikis D; Corcos L
Sci Rep; 2019 Jul; 9(1):9743. PubMed ID: 31278324
[TBL] [Abstract][Full Text] [Related]
11. High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases.
Brunsell TH; Sveen A; Bjørnbeth BA; Røsok BI; Danielsen SA; Brudvik KW; Berg KCG; Johannessen B; Cengija V; Abildgaard A; Guren MG; Nesbakken A; Lothe RA
Clin Colorectal Cancer; 2020 Mar; 19(1):e26-e47. PubMed ID: 31982351
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of F18-FDG PET radiomic features for different cervical tumor segmentation methods, gray-level discretization, and reconstruction algorithms.
Altazi BA; Zhang GG; Fernandez DC; Montejo ME; Hunt D; Werner J; Biagioli MC; Moros EG
J Appl Clin Med Phys; 2017 Nov; 18(6):32-48. PubMed ID: 28891217
[TBL] [Abstract][Full Text] [Related]
13. Radiogenomic Analysis of Papillary Thyroid Carcinoma for Prediction of Cervical Lymph Node Metastasis: A Preliminary Study.
Tong Y; Sun P; Yong J; Zhang H; Huang Y; Guo Y; Yu J; Zhou S; Wang Y; Wang Y; Ji Q; Wang Y; Chang C
Front Oncol; 2021; 11():682998. PubMed ID: 34268116
[TBL] [Abstract][Full Text] [Related]
14. Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
Løes IM; Immervoll H; Sorbye H; Angelsen JH; Horn A; Knappskog S; Lønning PE
Int J Cancer; 2016 Aug; 139(3):647-56. PubMed ID: 26991344
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.
Karagkounis G; Torbenson MS; Daniel HD; Azad NS; Diaz LA; Donehower RC; Hirose K; Ahuja N; Pawlik TM; Choti MA
Cancer; 2013 Dec; 119(23):4137-44. PubMed ID: 24104864
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study.
Javed S; Benoist S; Devos P; Truant S; Guimbaud R; Lièvre A; Sefrioui D; Cohen R; Artru P; Dupré A; Bachet JB; de la Fouchardière C; Ploquin A; Turpin A
World J Surg Oncol; 2022 Apr; 20(1):131. PubMed ID: 35461290
[TBL] [Abstract][Full Text] [Related]
17. 4D radiomics: impact of 4D-CBCT image quality on radiomic analysis.
Zhang Z; Huang M; Jiang Z; Chang Y; Torok J; Yin FF; Ren L
Phys Med Biol; 2021 Feb; 66(4):045023. PubMed ID: 33361574
[TBL] [Abstract][Full Text] [Related]
18. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Dohan A; Gallix B; Guiu B; Le Malicot K; Reinhold C; Soyer P; Bennouna J; Ghiringhelli F; Barbier E; Boige V; Taieb J; Bouché O; François E; Phelip JM; Borel C; Faroux R; Seitz JF; Jacquot S; Ben Abdelghani M; Khemissa-Akouz F; Genet D; Jouve JL; Rinaldi Y; Desseigne F; Texereau P; Suc E; Lepage C; Aparicio T; Hoeffel C;
Gut; 2020 Mar; 69(3):531-539. PubMed ID: 31101691
[TBL] [Abstract][Full Text] [Related]
19. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
Nakayama I; Shinozaki E; Matsushima T; Wakatsuki T; Ogura M; Ichimura T; Ozaka M; Takahari D; Suenaga M; Chin K; Mizunuma N; Yamaguchi K
BMC Cancer; 2017 Jan; 17(1):38. PubMed ID: 28068936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
